Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults - Scorecard - MDSpire

Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults

  • By

  • Mark McMillan

  • Hassen Mohammed

  • Jim Buttery

  • Margaret Angliss

  • Belinda Barton

  • Christopher C. Blyth

  • Suja M. Mathew

  • Morgyn S. Warner

  • Renjy Nelson

  • Rory Hannah

  • Naomi Runnegar

  • Helen Siobhan Marshall

  • May 18, 2026

  • 0 min

Share

Clinical Scorecard: Late diagnosis linked to complications in Australian adolescents and young adults with invasive meningococcal disease

At a Glance

CategoryDetail
ConditionInvasive Meningococcal Disease (IMD)
Key MechanismsCaused by Neisseria meningitidis, presenting as septicaemia or meningitis.
Target PopulationAdolescents and young adults aged 15 to 24 years.
Care SettingMajor tertiary referral hospitals across Australia.

Key Highlights

  • 143 cases of IMD reported in Australia in 2023, a 14% increase from 2022.
  • Serogroup B accounts for 84% of IMD cases in Australia.
  • Delayed diagnosis leads to increased morbidity and mortality, with case fatality rates of 10-15%.

Guideline-Based Recommendations

Diagnosis

  • Early recognition of symptoms such as fever, headache, and rash is critical.
  • Classical meningeal signs may be absent at initial assessment.

Management

  • Prompt clinical assessment and triage are essential.
  • Immediate antibiotic administration is crucial to reduce complications.

Monitoring & Follow-up

  • Patients often require intensive care management during the acute phase.
  • Monitoring for long-term sequelae is necessary for survivors.

Risks

  • Delays in treatment can lead to shock and multi-organ failure.
  • Up to 61% of young adult survivors may experience lasting sequelae.

Patient & Prescribing Data

Adolescents and young adults aged 15 to 24 years.

Timely antibiotic treatment is linked to better outcomes.

Clinical Best Practices

  • Ensure rapid triage and assessment in emergency settings.
  • Educate healthcare providers on recognizing early signs of IMD.

Related Resources & Content

Original Source(s)

Related Content